|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E-mail contact: kurt.ballmer@psi.ch
Vascular endothelial growth factors (VEGFs) interact with the receptor tyrosine kinases (RTKs) VEGFR-1, -2, and -3; neuropilins (NRPs); and heparan sulfate (HS) proteoglycans. VEGF RTKs signal to downstream targets upon ligand-induced tyrosine phosphorylation, while NRPs and HS act as coreceptors that lack enzymatic activity yet modulate signal output by VEGF RTKs. VEGFs exist in various isoforms with distinct receptor specificity and biological activity. Here, a series of mammalian VEGF-A splice variants and orf virus VEGF-Es, as well as chimeric and mutant VEGF variants, were characterized to determine the motifs required for binding to NRP-1 in the absence (VEGF-E) or presence (VEGF-A165) of an HS-binding sequence. We identified the carboxyterminal peptides RPPR and DKPRR as the NRP-1 binding motifs of VEGF-E and VEGF-A, respectively. RPPR had significantly higher affinity for NRP-1 than DKPRR. VEGFs containing an RPPR motif promoted HS-independent coreceptor complex assembly between VEGFR-2 and NRP-1, independent of whether these receptors were expressed on the same or separate cells grown in cocultures. Functional studies showed that stable coreceptor assembly by VEGF correlated with its ability to promote vessel formation in an embryoid body angiogenesis assay.—Cébe-Suarez, S., Grünewald, F. S., Jaussi, R., Li, X., Claesson-Welsh, L., Spillmann, D., Mercer, A. A., Prota, A. E., Ballmer-Hofer, K. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR.
This article has been cited by other articles:
![]() |
R. J. Giordano, M. Cardo-Vila, A. Salameh, C. D. Anobom, B. D. Zeitlin, D. H. Hawke, A. P. Valente, F. C. L. Almeida, J. E. Nor, R. L. Sidman, et al. From combinatorial peptide selection to drug prototype (I): Targeting the vascular endothelial growth factor receptor pathway PNAS, March 16, 2010; 107(11): 5112 - 5117. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.-M. Leppanen, A. E. Prota, M. Jeltsch, A. Anisimov, N. Kalkkinen, T. Strandin, H. Lankinen, A. Goldman, K. Ballmer-Hofer, and K. Alitalo Structural determinants of growth factor binding and specificity by VEGF receptor 2 PNAS, February 9, 2010; 107(6): 2425 - 2430. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tremmel, A. Matzke, I. Albrecht, A. M. Laib, V. Olaku, K. Ballmer-Hofer, G. Christofori, M. Heroult, H. G. Augustin, H. Ponta, et al. A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis Blood, December 10, 2009; 114(25): 5236 - 5244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lambert, M. Bouttier, R. Vassy, M. Seigneuret, C. Petrow-Sadowski, S. Janvier, N. Heveker, F. W. Ruscetti, G. Perret, K. S. Jones, et al. HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165 Blood, May 21, 2009; 113(21): 5176 - 5185. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kawamura, X. Li, K. Goishi, L. A. van Meeteren, L. Jakobsson, S. Cebe-Suarez, A. Shimizu, D. Edholm, K. Ballmer-Hofer, L. Kjellen, et al. Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization Blood, November 1, 2008; 112(9): 3638 - 3649. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |